| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-04-3262 |
| P698 | PubMed publication ID | 15604267 |
| P50 | author | James Lewis Abbruzzese | Q14947937 |
| Donghui Li | Q112692814 | ||
| Jijiang Zhu | Q114423657 | ||
| P2093 | author name string | Jianjun Shen | |
| Maria D Person | |||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| pancreatic adenocarcinoma | Q18556189 | ||
| P304 | page(s) | 9018-9026 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. | |
| P478 | volume | 64 |
| Q28264735 | 14-3-3 zeta as novel molecular target for cancer therapy |
| Q34473399 | 14-3-3ζ as a prognostic marker and therapeutic target for cancer |
| Q36313730 | 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications |
| Q58608641 | A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts |
| Q35337546 | A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours |
| Q30532006 | AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D |
| Q38034447 | Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective |
| Q34751614 | An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer |
| Q37839040 | An overview of cyclophilins in human cancers |
| Q38000324 | Application of NMR metabolomics to search for human disease biomarkers |
| Q28276398 | Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach |
| Q39274516 | Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium. |
| Q34105623 | Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma |
| Q33984836 | Comparative proteomic and radiobiological analyses in human lung adenocarcinoma cells |
| Q36711064 | Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis |
| Q41334598 | Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression |
| Q33676456 | Cordyceps cicadae induces G2/M cell cycle arrest in MHCC97H human hepatocellular carcinoma cells: a proteomic study |
| Q34029016 | Current implications of cyclophilins in human cancers. |
| Q89355327 | Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland |
| Q37297666 | Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular Carcinoma |
| Q39841617 | Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells |
| Q54474404 | Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. |
| Q33532354 | Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q. |
| Q51488757 | Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens. |
| Q33696888 | Discovery of Novel Cyclophilin A Ligands Using an H/D Exchange– and Mass Spectrometry–Based Strategy |
| Q28505046 | Dual role of peroxiredoxin I in macrophage-derived foam cells |
| Q36462824 | Endoplasmic reticulum stress and unfolded protein response in Atm-deficient thymocytes and thymic lymphoma cells are attributable to oxidative stress |
| Q34413448 | Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy. |
| Q30620697 | Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation |
| Q46864651 | Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells |
| Q36379734 | Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy |
| Q37772497 | Gene-expression profiling in pancreatic cancer |
| Q33278299 | Genes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cells |
| Q34657038 | Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine |
| Q36184419 | Genomics of pancreatic cancer: does it make any improvement in diagnosis, prognosis and therapy? |
| Q38791962 | Glucose metabolic phenotype of pancreatic cancer. |
| Q33569131 | HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma |
| Q36202451 | Helicobacter pylori disrupts host cell membranes, initiating a repair response and cell proliferation |
| Q36559876 | High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner |
| Q28118786 | Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2 |
| Q34496963 | Identification of Annexin A4 as a hepatopancreas factor involved in liver cell survival |
| Q36708826 | Identification of HIV inhibitors guided by free energy perturbation calculations |
| Q38437145 | Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells |
| Q33267541 | Identification of poly(ADP-ribose)polymerase-1 and Ku70/Ku80 as transcriptional regulators of S100A9 gene expression |
| Q28288078 | Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach |
| Q28276022 | Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer |
| Q36328508 | Identifying molecular markers for the early detection of pancreatic neoplasia |
| Q58779449 | Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker |
| Q33756453 | Infection with dengue-2 virus alters proteins in naturally expectorated saliva of Aedes aegypti mosquitoes |
| Q35131817 | Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 |
| Q36432498 | Inhibition and detection of galectins. |
| Q30319101 | Isoform-specific inhibition of cyclophilins |
| Q39950398 | Knockdown endogenous CypA with siRNA in U2OS cells results in disruption of F-actin structure and alters tumor phenotype |
| Q34372855 | Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-κB. |
| Q38780454 | Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach |
| Q41932796 | Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis? |
| Q36424134 | MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance |
| Q37614592 | Molecular changes in pancreatic cancer |
| Q37081461 | Molecular markers of pancreatic cancer: development and clinical relevance |
| Q36166133 | Muscadine Grape Skin Extract Induces an Unfolded Protein Response-Mediated Autophagy in Prostate Cancer Cells: A TMT-Based Quantitative Proteomic Analysis |
| Q35931023 | Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators |
| Q39644444 | Novel combinational treatment of cisplatin with cyclophilin a inhibitors in human heptocellular carcinomas |
| Q36135837 | Novel immunohistochemical marker, integrin α(V)β(3), for BOP-induced early lesions in hamster pancreatic ductal carcinogenesis |
| Q37447976 | Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction |
| Q28285857 | Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma |
| Q53205814 | Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma. |
| Q34027390 | PROFESS: a PROtein function, evolution, structure and sequence database |
| Q36495168 | PancPRO: risk assessment for individuals with a family history of pancreatic cancer |
| Q30483618 | Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets |
| Q26741215 | Pancreatic cancer stem cell markers and exosomes - the incentive push |
| Q35111396 | Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma |
| Q34204503 | Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4 |
| Q79781979 | Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer |
| Q93215740 | Polyphenol Extracts from Red Wine and Grapevine: Potential Effects on Cancers |
| Q35058538 | Prioritization of cancer marker candidates based on the immunohistochemistry staining images deposited in the human protein atlas |
| Q64981326 | Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung. |
| Q24658240 | Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells |
| Q61855549 | Protein expression patterns associated with advanced stage ovarian cancer |
| Q33245462 | Protein fragment domains identified using 2D gel electrophoresis/MALDI-TOF. |
| Q60609764 | Proteomanalyse |
| Q38372053 | Proteome Characterization of Human Pancreatic Cyst Fluid from Intraductal Papillary Mucinous Neoplasm by LC/MS/MS. |
| Q33302217 | Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection |
| Q39642084 | Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray |
| Q80305915 | Proteome analysis of human pancreatic ductal adenocarcinoma tissue using two-dimensional gel electrophoresis and tandem mass spectrometry for identification of disease-related proteins |
| Q34073892 | Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases. |
| Q43008803 | Proteome-based biomarkers in pancreatic cancer |
| Q21260399 | Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients |
| Q51817159 | Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE. |
| Q36011264 | Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry |
| Q33864628 | Proteomic analysis of pancreatic intraepithelial neoplasia and pancreatic carcinoma in rat models |
| Q33938187 | Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. |
| Q33325583 | Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma |
| Q31071791 | Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice |
| Q33458493 | Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma |
| Q83414403 | Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers |
| Q46296450 | Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma. |
| Q36026306 | Proteomic profiling of pancreatic cancer for biomarker discovery |
| Q91585578 | Proteomics Profiling of Pancreatic Cancer and Pancreatitis for Biomarkers Discovery |
| Q37113899 | Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma |
| Q33293341 | Proteomics in cancer. |
| Q36772529 | Proteomics studies of pancreatic cancer |
| Q37416043 | Quantitative proteomics investigation of pancreatic intraepithelial neoplasia |
| Q33882818 | Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation |
| Q47843325 | Real-time dynamic SERS detection of galectin using glycan-decorated gold nanoparticles |
| Q26740191 | Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy |
| Q35277008 | Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology |
| Q34412619 | Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arrays |
| Q37716918 | Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer |
| Q38184491 | Review of the CE-MS platform as a powerful alternative to conventional couplings in bio-omics and target-based applications |
| Q34700918 | S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway |
| Q38805063 | Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics |
| Q64103178 | Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma |
| Q24564006 | Strategies for early detection of resectable pancreatic cancer |
| Q37970918 | Targeting 14-3-3zeta in cancer therapy |
| Q52333009 | Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk. |
| Q34608851 | The current state of proteomics in GI oncology |
| Q46317117 | The differential role of reactive oxygen species in early and late stages of cancer |
| Q39373589 | The feasibility of enzyme targeted activation for amino acid/dipeptide monoester prodrugs of floxuridine; cathepsin D as a potential targeted enzyme |
| Q37153303 | The molecular biology of pancreatic cancer |
| Q28084488 | The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development |
| Q35450240 | The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas |
| Q46149679 | Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer |
| Q38099731 | Three are better than one: plasminogen receptors as cancer theranostic targets. |
| Q26824034 | Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges |
| Q39643742 | Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets |
| Q54657364 | Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. |
| Q37831975 | α-Enolase: a promising therapeutic and diagnostic tumor target. |
Search more.